National trends in discharge disposition after hepatic resection for malignancy

HPB

Volumn 13, Issue 2, 2011, Pages 96-102

  Shah, Bhavin C ^a   Ullrich, Fred ^b   Smith, Lynette ^b   Leiphrakpam, Premila ^b   Ly, Quan ^a,b   Sasson, Aaron ^a,b   Are, Chandrakanth ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

age; co morbidities; discharge disposition; hepatic resection

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; HEALTH CARE FACILITY; HOME CARE; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; LIVER CANCER; LIVER RESECTION; LOBECTOMY; MAJOR CLINICAL STUDY; WEDGE RESECTION;

EID: 78751662637     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00251.x     Document Type: Article

References (24)

1. Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr,. (2003) Hepatic resection in the United States: indications, outcomes and hospital procedural volumes from a nationally representative database. Arch Surg 138: 185-191.
2. Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol JA, Colletti LM,. (2004) National trends in the use and outcomes of hepatic resection. J Am Coll Surg 199: 31-38.
3. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, et al. (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250: 440-448.
4. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. (2007) Actual 10-year survival after resection of colorectal metastasis defines cure. J Clin Oncol 25: 4575-4580.
5. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27: 3677-3683.
6. Nathan H, Raut CP, Thornton K, Herman JM, Ahuja N, Schulick RD, et al. (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249: 799-805.
7. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the last decade. Ann Surg 236: 397-406.
8. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138: 1198-1206.
9. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229: 322-330.
10. Huang ZQ, Xu LN, Yang T, Zhang WZ, Huang XQ, Cai SW, et al. (2009) Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J 122: 2268-2277.
11. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, et al. (2009) Predicting poor outcomes following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) 11: 510-515.
12. Elixhauser A, Steiner C, Harris DR, Coffey RM,. (1998) Comorbidity measures for use with administrative data. Med Care 36: 8-27.
13. Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, et al. (2010) Liver resection of colorectal metastases in elderly patients. Br J Surg 97: 366-376.
14. Brand MI, Saclarides TJ, Dobson HD, Millikan KW,. (2000) Liver resection for colorectal cancer: liver metastases in the aged. Am Surg 66: 412-415. discussion 415-416.
15. Sgourakis G, Sotiropoulos GC, Bockhorn M, Fouzas I, Radtke A, Molmenti EP, et al. (2009) Major liver resections for primary liver malignancies in the elderly. Acta Chir Belg 109: 340-344.
16. Mirici-Cappa F, Gramenzi A, Santi V, Zambruni A, Di Micoli A, Frigerio M, et al. (2010) Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 59: 387-396.
17. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, et al. (2007) Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 204: 1284-1292.
18. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466.
19. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM,. (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200: 845-853.
20. Morris-Stiff G, Tan YM, Vauthey JN., (2008) Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 34: 609-614. Epub 2007.
21. Abdalla EK, Vauthey JN,. (2008) Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg 25: 421-429. Epub 2009 Feb 12.
22. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, et al. (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7: 1034-1044.
23. Nguyen KT, Gamblin TC, Geller D,. (2009) World review of laparoscopic liver resection-2804 patients. Ann Surg 250: 831-841.
24. Lai EC, Tang CN, Ha JP, Li MK,. (2009) Laparoscopic liver resection for hepatocellular carcinoma: ten-year experience in a single center. Arch Surg 144: 143-147. discussion 148.